CD8A and neoplasm: Despite FK506 decreased PD-1-expressing CD4+ and CD8+ T cells in the blood of control mice, these alterations were not observed in C26 tumor-bearing mice (Figure 4J), suggesting that FK506 does not affect tumor immune escape.